Neutral impactResults

Excelsoft Technologies Limited — Monitoring Agency Report

NSE 1 hr ago·5 Nov 2026, 1:23 pm
Excelsoft Technologies L

Monitoring Agency Report Q2 FY27

Affected stocks

Neutral1 stock

Excelsoft Technologies L

EXCELSOFT Neutral

₹80.93

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Excelsoft Technologies L (EXCELSOFT).
  • Category: Results.

Why it matters

A routine update for Excelsoft Technologies L. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news
Aditya Infotech

Aditya Infotech Limited — Acquisition (including agreement to acquire)-XBRL

Aditya Infotech₹3,999.80▼ 4.09%

NSE · 1 hr ago

DR Agarwals Health Care L

Dr. Agarwal's Health Care Limited — Alteration Of Capital and Fund Raising-XBRL

DR Agarwals Health Care L₹523.50▲ 2.31%

NSE · 1 hr ago

Mahindra & Mahindra

Mahindra & Mahindra Limited — Analyst/Investor Meet Para A-XBRL

Mahindra & Mahindra₹2,961.90▼ 5.29%

NSE · 1 hr ago

Veedol Corporation

Veedol Corporation Limited — Change in Management

Veedol Corporation₹1,412.80▼ 1.02%

NSE · 1 hr ago

Sunteck Realty

Sunteck Realty Limited — Acquisition of 'to be incorporated companies'-XBRL

Sunteck Realty₹293.70▼ 1.46%

NSE · 1 hr ago

Company NSE

Valecha Engineering Limited — Board Meeting Intimation

NSE · 1 hr ago

Sunteck Realty

Sunteck Realty Limited — Acquisition

Sunteck Realty₹293.70▼ 1.46%

NSE · 1 hr ago

Sula Vineyards

Sula Vineyards Limited — Investor Presentation

Sula Vineyards₹134.85▼ 2.12%

NSE · 1 hr ago

THE Byke Hospitality

The Byke Hospitality Ltd — Outcome of Board Meeting

THE Byke Hospitality₹29.88▼ 1.87%

NSE · 1 hr ago

Latest headlines

More news
Economy RBI

RBI to conduct 3-day Variable Rate Reverse Repo (VRRR) auction under LAF on November 06, 2026

RBI · 59 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.